SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.
作者信息
Lei Yuyang, Zhang Jiao, Schiavon Cara R, He Ming, Chen Lili, Shen Hui, Zhang Yichi, Yin Qian, Cho Yoshitake, Andrade Leonardo, Shadel Gerald S, Hepokoski Mark, Lei Ting, Wang Hongliang, Zhang Jin, Yuan Jason X-J, Malhotra Atul, Manor Uri, Wang Shengpeng, Yuan Zu-Yi, Shyy John Y-J
机构信息
Cardiology, First Affiliated Hospital of Xi'an Jiaotong University (Y.L., Jiao Zhang, Z.-Y.Y.).
Cardiovascular Research Center, School of Basic Medical Sciences (Y.L., Jiao Zhang, L.C., Q.Y., S.W.).
出版信息
Circ Res. 2021 Apr 30;128(9):1323-1326. doi: 10.1161/CIRCRESAHA.121.318902. Epub 2021 Mar 31.
Abstract
摘要
相似文献
1
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.
Circ Res. 2021 Apr 30;128(9):1323-1326. doi: 10.1161/CIRCRESAHA.121.318902. Epub 2021 Mar 31.
2
Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.
Chem Commun (Camb). 2021 Apr 4;57(26):3283-3286. doi: 10.1039/d0cc08387a. Epub 2021 Mar 2.
3
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein.
Clin Transl Med. 2021 Feb;11(2):e281. doi: 10.1002/ctm2.281.
4
Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19.
Clin Transl Med. 2021 Apr;11(4):e371. doi: 10.1002/ctm2.371.
5
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
Signal Transduct Target Ther. 2021 May 18;6(1):198. doi: 10.1038/s41392-021-00619-y.
6
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
7
Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
Front Immunol. 2022 Feb 4;13:776861. doi: 10.3389/fimmu.2022.776861. eCollection 2022.
8
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.
Am J Respir Cell Mol Biol. 2021 Apr;64(4):407-415. doi: 10.1165/rcmb.2020-0359PS.
9
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Viruses. 2021 Feb 28;13(3):384. doi: 10.3390/v13030384.
10
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox.
Infect Control Hosp Epidemiol. 2021 Jan;42(1):118-119. doi: 10.1017/ice.2020.195. Epub 2020 May 4.
引用本文的文献
1
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?
Int J Mol Sci. 2025 Aug 15;26(16):7879. doi: 10.3390/ijms26167879.
2
SARS-CoV-2 spike treatment and transfection impairs airway epithelial repair.
ERJ Open Res. 2025 Aug 4;11(4). doi: 10.1183/23120541.00940-2024. eCollection 2025 Jul.
3
Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects.
Diseases. 2025 Jun 30;13(7):204. doi: 10.3390/diseases13070204.
4
Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration.
Int J Mol Sci. 2025 Jun 27;26(13):6214. doi: 10.3390/ijms26136214.
5
Naturally Occurring Angiotensin Peptides Enhance the SARS-CoV-2 Spike Protein Binding to Its Receptors.
Int J Mol Sci. 2025 Jun 24;26(13):6067. doi: 10.3390/ijms26136067.
6
Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein.
Stem Cell Res Ther. 2025 Jul 1;16(1):324. doi: 10.1186/s13287-025-04472-6.
7
SARS-CoV-2 infection promotes lung thrombosis by inducing integrinβ3 expression in vascular endothelial cells.
Sci Rep. 2025 Jul 1;15(1):20447. doi: 10.1038/s41598-025-02784-4.
8
SARS-CoV-2 (MA10) Infection Aggravates Cerebrovascular Pathology in Endothelial Nitric Oxide Synthase-Deficient Mice.
Viruses. 2025 May 29;17(6):784. doi: 10.3390/v17060784.
9
Effects of coronavirus disease 2019 on the incidence, mortality, and prognosis of ischemic stroke: a systematic review and meta-analysis.
Front Neurol. 2025 May 13;16:1486887. doi: 10.3389/fneur.2025.1486887. eCollection 2025.
10
SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome.
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
本文引用的文献
1
MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
Circulation. 2020 Sep 22;142(12):1190-1204. doi: 10.1161/CIRCULATIONAHA.120.048191. Epub 2020 Jul 28.
2
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.
Cell Metab. 2020 Sep 1;32(3):437-446.e5. doi: 10.1016/j.cmet.2020.07.007. Epub 2020 Jul 17.
3
COVID-19: the vasculature unleashed.
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
4
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.
Zotero 插件